% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Schttler:136807,
      author       = {C. Schüttler and N. Buschhüter and C. Döllinger and L.
                      Ebert$^*$ and M. Hummel and J. Linde and H.-U. Prokosch and
                      R. Proynova$^*$ and M. Lablans$^*$},
      title        = {[{R}equirements for a cross-location biobank {IT}
                      infrastructure : {S}urvey of stakeholder input on the
                      establishment of a biobank network of the {G}erman
                      {B}iobank {A}lliance ({GBA})].},
      journal      = {Der Pathologe},
      volume       = {39},
      number       = {4},
      issn         = {1432-1963},
      address      = {Berlin},
      publisher    = {Springer},
      reportid     = {DKFZ-2018-01245},
      pages        = {289 - 296},
      year         = {2018},
      abstract     = {The large number of biobanks within Germany results in
                      a high degree of heterogeneity with regard to the IT
                      components used at the respective locations. Within the
                      German Biobank Alliance (GBA), 13 biobanks implement
                      harmonized processes for the provision of biomaterial and
                      accompanying data.The networking of the individual biobanks
                      and the associated harmonisation of the IT infrastructure
                      should facilitate access to biomaterial and related clinical
                      data.For this purpose, the relevant target groups were first
                      identified in order to determine their requirements for IT
                      solutions to be developed in a workshop.Of the seven
                      identified interest groups, three were initially invited to
                      a first round of discussions. The stakeholder input
                      expressed resulted in a catalogue of requirements with
                      regard to IT support for (i) a sample and data request,
                      (ii) the handling of patient consent and inclusion,
                      and (iii) the subsequent evaluation of the sample and data
                      request.The next step is to design the IT solutions as
                      prototypes based on these requirements. In parallel,
                      further user groups are being surveyed in order to be able
                      to further concretise the specifications for development.},
      subtyp        = {Review Article},
      cin          = {G230},
      ddc          = {610},
      cid          = {I:(DE-He78)G230-20160331},
      pnm          = {317 - Translational cancer research (POF3-317)},
      pid          = {G:(DE-HGF)POF3-317},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:29691676},
      doi          = {10.1007/s00292-018-0435-9},
      url          = {https://inrepo02.dkfz.de/record/136807},
}